Dr Nancy E. Lane is the Leader of the Regenerative Medicine R&D Team in the United States, an Elected Member of the National Academy of Medicine (USA), and one of the key inventors of the novel drug LLP2A-Ale (RAB001). Internationally renowned, Dr. Lane is a preeminent scientist in the fields of osteoporosis and osteoarthritis.

Dr. Lane previously chaired the Board of Directors of the U.S. Bone and Joint Decade Initiative (now known as the Decade of Bone and Joint Initiative). She is an Elected Member of the American Association for the Advancement of Science (AAAS) Council and has held leadership positions within the American Society for Bone and Mineral Research (ASBMR) and the Orthopaedic Research Society (ORS). Dr. Lane also serves as Associate Editor for *Nature Reviews Rheumatology* and *Seminars in Arthritis and Rheumatism*, and as an Editorial Board Member of *The Journal of Rheumatology*.

Her distinctions include being an Elected Member of the Association of American Physicians (AAP) and the Institute of Medicine (IOM) of the National Academies (now part of the National Academy of Medicine). She has been consistently recognized as one of America's Top Doctors® annually since 2004 in the specialty of Rheumatology.